Brief: ALX Oncology Posts Q4 net loss USD30.709 million
09/03/2023 21:02
Mar 9 (Reuters) - ALX Oncology Q4 basic EPS USD -0.75. * Q4 operating expenses USD 32.219 million * Q4 income from operations USD -32.219 million * Q4 net income USD -30.709 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing